Find a Doctor
Browse UPMC doctors and medical professionals to find the care that's right for you. Customize your search by specialty, zip code, last name, and more.
Visit the UPMC Find a Doctor website.
Most UPMC cancer care in western Pennsylvania, including the flagship UPMC Hillman Cancer Center located at UPMC Shadyside, will be out-of-network for Highmark commercial plan members after June 30, 2019. The special protection for oncology care created by the Consent Decrees will no longer exist.
However, some UPMC cancer care facilities in western Pa., including those operated in conjunction with other community health care providers, will remain in-network for at least two years after the Consent Decrees expire on June 30, 2019.
Read more about cancer care in Western PA, including FAQs.
The intersection between the funding of medical care for clinical trials and rules governing in-network or out-of-network access to medical facilities and services can be complex. At UPMC, we seek to place the patients’ interests first and allow for continuity of their care between the trial site and the patient’s in-network providers. UPMC will make every effort to avoid disruption of a patient’s participation in a trial or his/her access to in-network care unrelated to research.
Below are some answers to frequently asked questions on this topic.
Q. What if I have Highmark insurance, but am enrolled in a clinical trial in the greater Pittsburgh or Erie area? Or, want to enroll in a trial in the future?
A. Even if you have Highmark or other BCBS insurance and become out-of-network at UPMC after June 30, 2019, you may be able to continue in a clinical trial in which you enrolled prior to June 30, and you may enroll in a new clinical trial. Most clinical trials have sponsors; the sponsor — a company, government entity, foundation, or other source — pays to test its new medicines, care plans, or products. These sponsored trials cover many medical expenses associated with a patient’s trial participation. Other medical services related to your treatment during the trial, as well as follow-up care after participation in the trial has ended, can be obtained on an in-network basis from a provider in your network, subject to any necessary monitoring by the doctors running the trial.
In some clinical trials, patients are asked to self-report their actions and/or health status over an extended period of time. You would continue to see in-network providers for any medical care needed during this period, so your care would be covered by your insurance.
It is also possible that you could participate in a clinical trial at a UPMC hospital or cancer center location that will remain in-network after June 30, 2019 (see listing above).
Q. What if I have Highmark insurance and I am being followed/monitored after completing a clinical trial at UPMC in the greater Pittsburgh or Erie area?
A. If you become out-of-network at UPMC after June 30, 2019, but still need follow-up care after your participation in a UPMC clinical trial, you should be able to obtain that care on an in-network basis from a provider in your network. The doctors running the trial may need to monitor the follow-up care that you receive from another provider, so you should discuss your care planning and insurance situation with the trial’s administrators.
Q. What if I am participating in a clinical trial at a UPMC hospital or UPMC cancer center in western PA that will remain in-network after June 30, 2019?
A. Some UPMC hospitals in western Pennsylvania, as well as a number of UPMC Hillman Cancer Center locations, will remain in-network for most Highmark members after June 30, 2019. If you are currently participating in a clinical trial at one of these locations, or are considering it, you can expect to be able to continue your participation after June 30, 2019. However, you should consult the administrators of the trial in advance to confirm your status.